carbostyril has been researched along with Bacterial Infections, Gram-Positive in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 13 (34.21) | 18.2507 |
2000's | 16 (42.11) | 29.6817 |
2010's | 8 (21.05) | 24.3611 |
2020's | 1 (2.63) | 2.80 |
Authors | Studies |
---|---|
Aboshanab, KM; Elshamy, AA; Hassouna, NA; Yassien, MA | 1 |
Gotoh, N; Hayashi, N; Ikeda, F; Ishii, R; Kanayama, S; Matsumoto, T; Okamoto, K | 1 |
Atanaskovic-Markovic, M; Barbaud, A; Bircher, A; Blanca, M; Brockow, K; Caubet, JC; Celik, GE; Cernadas, JR; Chiriac, A; Demoly, P; Garvey, LH; Merk, HF; Mosbech, H; Nakonechna, A; Romano, A; Torres, MJ; Whitaker, P | 1 |
Stamatiou, K | 1 |
Cantón, R; Espinal, P; Garcia-Alonso, F; Gargallo-Viola, D; López, Y; Tato, M; Vila, J | 1 |
Kim, MC; Woo, GJ | 1 |
Alam, MR; Garg, P; Gopinathan, U; Krishnaiah, S; Reddy, AK; Sharma, S | 1 |
Chen, YH; Hsueh, PR; King, CH; Liu, CY; Lu, JJ | 1 |
Cen, S; Huang, P; Jiang, JD; Li, CR; Li, GQ; Li, Y; Liu, JF; Lou, RH; Yang, XY; You, XF; Yu, LY; Yuan, M; Zhang, WX; Zhao, LX | 1 |
Fraser, A; Gafter-Gvili, A; Kremer, LC; Lawrie, TA; Leibovici, L; Paul, M; van de Wetering, MD; Vidal, L | 1 |
Bello, A; Gajjar, DA; Grasela, DM; Meurling, L; Nord, CE; Russo, RL | 1 |
Bilker, WB; Fishman, NO; Gould, CV; LaRosa, LA; Lautenbach, E; Marr, AM; Nachamkin, I | 1 |
Archimandritis, AJ; Cholongitas, E; Kontou-Kastellanou, C; Lahanas, A; Papatheodoridis, GV; Xanthaki, A | 1 |
Fraser, A; Gafter-Gvili, A; Kremer, L; Leibovici, L; Paul, M; van de Wetering, M | 1 |
Ho, DH; Kontoyiannis, DP; Raad, II; Rolston, KV; Yadegarynia, D | 1 |
Bonten, MJ; Leavis, HL; Willems, RJ | 1 |
Black, JA; Hanson, ND; Hong, SG; Hossain, A; Moland, ES; Thomson, KS; Wickman, PA | 1 |
Bradbury, BJ; Buechter, DD; Cheng, J; Deshpande, M; Mushtaq, G; Podos, SD; Pucci, MJ; Thanassi, JA; Thoma, CL; Vigliotti, GA | 1 |
Esposito, S; Ianniello, F; Leone, S; Noviello, S | 1 |
Cavana, P; Farca, AM; Nebbia, P; Robino, P | 1 |
Asbroek, M; Bonten, M; Top, J; van der Velden, S; Willems, R | 1 |
Kozai, S; Ohashi, Y; Sakaki, H; Suzuki, T; Tajika, T; Wada, T | 1 |
Datsenko, BM; Tamm, TI | 1 |
Sobestiansky, J; Wendt, M | 1 |
Burney, S; Landman, D; Quale, JM | 1 |
Aoun, M; Bourguignon, AM; Daneau, D; Janssen, M; Meunier, F; Van der Auwera, P; Varthalitis, I | 1 |
Donabedian, SA; Perri, MB; Thal, LA; Vazquez, J; Zervos, MJ | 1 |
Tsuji, A | 1 |
Korten, V; Murray, BE; Tomayko, JF | 1 |
Bongaerts, GP; Hoogkamp-Korstanje, JA | 1 |
Amsterdam, D; Beam, TR; Gorzynski, EA; Mandell, LA; Rotstein, C | 1 |
Cohen, MA; Courtney, CL; Huband, MD; Roland, GE; Yoder, SL | 1 |
Burney, S; Landman, D; Quale, JM; Zaman, MM | 1 |
Beach, ML; Doern, GV; Jones, RN; Pfaller, MA | 1 |
Hatanaka, K; Hiraoka, A; Hosen, N; Karasuno, T; Kawamoto, S; Masaoka, T; Nakamura, H; Nakao, T; Teshima, H; Ujiie, H; Yagi, T | 1 |
Garau, J | 1 |
Jones, RN; Pfaller, MA; Stilwell, M | 1 |
Gordon, KA; Jones, RN; Pfaller, MA | 1 |
5 review(s) available for carbostyril and Bacterial Infections, Gram-Positive
Article | Year |
---|---|
Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Cause of Death; Drug Resistance, Bacterial; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Neoplasms; Neutropenia; Quinolones; Randomized Controlled Trials as Topic; Trimethoprim, Sulfamethoxazole Drug Combination | 2012 |
Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Neoplasms; Neutropenia; Quinolones; Randomized Controlled Trials as Topic; Trimethoprim, Sulfamethoxazole Drug Combination | 2005 |
Identification of high-risk enterococcal clonal complexes: global dispersion and antibiotic resistance.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Biological Evolution; Cross Infection; Disease Outbreaks; Drug Resistance; Drug Resistance, Bacterial; Enterococcus faecium; Europe; Genes, Bacterial; Genomic Islands; Gram-Positive Bacterial Infections; Humans; Molecular Epidemiology; Quinolones; United States; Virulence | 2006 |
[Gram-positive cocci (include MRSA)].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; Quinolones; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 1994 |
Update on cross-resistance of fluoroquinolones.
Topics: Anti-Infective Agents; Drug Resistance, Microbial; Gram-Positive Bacterial Infections; Humans; Quinolones; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2000 |
3 trial(s) available for carbostyril and Bacterial Infections, Gram-Positive
Article | Year |
---|---|
Effect of garenoxacin on eubacteria in the normal intestinal microflora when administered concomitantly with digoxin.
Topics: Administration, Oral; Adolescent; Biological Availability; Colony Count, Microbial; Digoxin; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Eubacterium; Feces; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Indoles; Intestinal Mucosa; Male; Microbial Sensitivity Tests; Prospective Studies; Quinolones; Sensitivity and Specificity | 2003 |
A prospective, randomized study of pefloxacin versus teicoplanin in the treatment of gram-positive coccal infections in cancer patients: early termination due to emergence of resistance to fluoroquinolones.
Topics: 4-Quinolones; Adult; Aged; Anti-Infective Agents; Bacteremia; Drug Resistance, Microbial; Drug Tolerance; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Pefloxacin; Pneumonia; Prospective Studies; Quinolones; Staphylococcal Infections; Teicoplanin | 1994 |
[New quinolone versus vancomycin/tobramycin for intestinal sterilization in patients who undergo allogeneic bone marrow transplantation].
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Bone Marrow Transplantation; Child; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Intestines; Middle Aged; Quinolones; Sterilization; Tobramycin; Transplantation Conditioning; Vancomycin | 1999 |
30 other study(ies) available for carbostyril and Bacterial Infections, Gram-Positive
Article | Year |
---|---|
Prevalence of plasmid-mediated resistance genes among multidrug-resistant uropathogens in Egypt.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Bacteriuria; beta-Lactam Resistance; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Egypt; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Plasmids; Prevalence; Pyuria; Quinolones; Sequence Analysis, DNA; Urinary Tract Infections | 2020 |
Bactericidal activity and post-antibiotic effect of ozenoxacin against Propionibacterium acnes.
Topics: Aminopyridines; Anti-Bacterial Agents; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Propionibacterium acnes; Quinolones | 2017 |
A EAACI drug allergy interest group survey on how European allergy specialists deal with β-lactam allergy.
Topics: Adult; Allergists; Anti-Bacterial Agents; beta-Lactams; Child; Drug Hypersensitivity; Europe; Female; Gram-Positive Bacterial Infections; Humans; Immunoglobulin E; Macrolides; Male; Nasal Provocation Tests; Quinolones; Skin Tests; Surveys and Questionnaires | 2019 |
The undefined role of Gram positive bacteria in chronic prostatitis development.
Topics: Anti-Bacterial Agents; Case-Control Studies; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Male; Prospective Studies; Prostatitis; Quinolones; Risk Factors; Sexual Behavior; Staphylococcus; Streptococcus mitis; Streptococcus oralis | 2013 |
In vitro selection of mutants resistant to ozenoxacin compared with levofloxacin and ciprofloxacin in Gram-positive cocci.
Topics: Aminopyridines; Anti-Bacterial Agents; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Quinolones; Selection, Genetic; Sequence Analysis, DNA | 2015 |
Characterization of antimicrobial resistance and quinolone resistance factors in high-level ciprofloxacin-resistant Enterococcus faecalis and Enterococcus faecium isolates obtained from fresh produce and fecal samples of patients.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Crops, Agricultural; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Feces; Food Contamination; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Quinolones | 2017 |
Comparison of in vitro susceptibilities of Gram-positive cocci isolated from ocular infections against the second and fourth generation quinolones at a tertiary eye care centre in South India.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacterial Infections; Humans; India; Male; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Retrospective Studies; Staphylococcus; Streptococcus | 2010 |
In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Mutation, Missense; Quinolones; Staphylococcus aureus; Streptococcus pneumoniae; Taiwan | 2009 |
In vivo antibacterial activity of nemonoxacin, a novel non-fluorinated quinolone.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Male; Mice; Microbial Sensitivity Tests; Pneumonia, Bacterial; Quinolones; Treatment Outcome; Urinary Tract Infections | 2010 |
Emergence of resistance to chloramphenicol among vancomycin-resistant enterococcal (VRE) bloodstream isolates.
Topics: Anti-Bacterial Agents; Bacteremia; Blood; Chloramphenicol; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Prevalence; Quinolones; Vancomycin Resistance | 2004 |
Increasing frequency of Gram-positive bacteria in spontaneous bacterial peritonitis.
Topics: Aged; Anti-Infective Agents; Ascites; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Liver Cirrhosis; Male; Middle Aged; Peritonitis; Quinolones | 2005 |
The spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Child; Child, Preschool; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Quinolones; Retrospective Studies | 2006 |
In vitro studies with DQ-113 and comparison fluoroquinolones to determine propensities to select resistance in gram-positive cocci.
Topics: Drug Resistance, Bacterial; Drug Resistance, Microbial; Fluoroquinolones; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Microbial Sensitivity Tests; Quinolones | 2007 |
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
Topics: Animals; Anti-Infective Agents; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Quinolones; Thiazoles | 2007 |
[In vitro activity of prulifloxacin, levofloxacin and ciprofloxacin against urinary pathogens].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dioxolanes; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Piperazines; Quinolones; Staphylococcus aureus; Urinary Tract Infections | 2006 |
In vitro antimicrobial activity of marbofloxacin and enrofloxacin against bacterial strains isolated from companion animals.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Colony Count, Microbial; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Quinolones; Treatment Outcome | 2007 |
Emergence of clonal complex 17 Enterococcus faecium in The Netherlands.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Cluster Analysis; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Genotype; Gram-Positive Bacterial Infections; Humans; Membrane Proteins; Minisatellite Repeats; Netherlands; Polymerase Chain Reaction; Quinolones; Vancomycin Resistance | 2008 |
Prophylactic efficacy of ophthalmic quinolones in experimental endophthalmitis in rabbits.
Topics: Animals; Anterior Chamber; Anti-Bacterial Agents; Biological Availability; Disease Progression; Endophthalmitis; Enterococcus faecalis; Eye; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacterial Infections; Male; Ofloxacin; Ointments; Ophthalmic Solutions; Quinolones; Rabbits | 2008 |
[The efficacy of the clinical use of the preparation Cifran in treating surgical infection].
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Drug Evaluation; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Intraoperative Care; Male; Middle Aged; Postoperative Care; Quinolones; Surgical Wound Infection; Tablets; Time Factors | 1994 |
[The therapy of urinary tract infections in sows].
Topics: Ampicillin; Animals; Anti-Infective Agents; Drug Therapy, Combination; Enrofloxacin; Eubacterium; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Quinolones; Swine; Swine Diseases; Urinary Tract Infections | 1995 |
Activity of clinafloxacin against multidrug-resistant Enterococcus faecium.
Topics: Ampicillin; Anti-Infective Agents; Drug Resistance, Multiple; Enterococcus faecium; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Kinetics; Microbial Sensitivity Tests; Quinolones | 1994 |
Sparfloxacin and clinafloxacin alone or in combination with gentamicin for therapy of experimental ampicillin-resistant enterococcal endocarditis in rabbits.
Topics: Ampicillin Resistance; Animals; Anti-Infective Agents; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Enterococcus faecium; Fluoroquinolones; Gentamicins; Gram-Positive Bacterial Infections; Quinolones; Rabbits; Random Allocation | 1993 |
Comparative in vitro activity of DU-6859a, a new fluoroquinolone agent, against gram-positive cocci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Fluoroquinolones; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Quinolones | 1994 |
In vitro activities of BAY Y3118, ciprofloxacin, ofloxacin, and fleroxacin against gram-positive and gram-negative pathogens from respiratory tract and soft tissue infections.
Topics: Anti-Infective Agents; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Quinolones; Respiratory Tract Infections | 1993 |
In vitro activity of sparfloxacin, ciprofloxacin, ofloxacin, and other antibiotics against bloodstream isolates of gram-positive cocci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1993 |
In vitro and in vivo activities of clinafloxacin, CI-990 (PD 131112), and PD 138312 versus enterococci.
Topics: Animals; Anti-Infective Agents; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Naphthyridines; Quinolones | 1995 |
Treatment of experimental endocarditis due to multidrug-resistant Enterococcus faecium with clinafloxacin and penicillin.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Fluoroquinolones; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Penicillins; Quinolones; Rabbits | 1996 |
Antimicrobial activity of gatifloxacin tested against 1676 strains of ciprofloxacin-resistant gram-positive cocci isolated from patient infections in North and South America.
Topics: Anti-Infective Agents; Antitubercular Agents; Bacteriological Techniques; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Naphthyridines; North America; Quinolones; South America | 1998 |
Activity and spectrum of BMS 284756, a new des-F (6) quinolone, tested against strains of ciprofloxacin-resistant Gram-positive cocci.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Indoles; Microbial Sensitivity Tests; Quinolones | 2001 |
BMS284756 (formerly T-3811, a des-fluoroquinolone) potency and spectrum tested against over 10,000 bacterial bloodstream infection isolates from the SENTRY antimicrobial surveillance programme (2000).
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Indoles; Microbial Sensitivity Tests; Population Surveillance; Quinolones | 2002 |